V-Square Quantitative Management’s GSK GSK Stock Holding History

V-Square Quantitative Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2M	Buy	42,017 +18,030	+75%	+$954K	0.21%	86
2026 Q1	$1.32M	Hold	23,987	–	–	0.14%	132
2025 Q4	$1.18M	Buy	23,987 +1,814	+8%	+$84.6K	0.12%	139
2025 Q3	$957K	Buy	22,173 +1,470	+7%	+$57.4K	0.16%	115
2025 Q2	$795K	Hold	20,703	–	–	0.11%	195
2025 Q1	$802K	Hold	20,703	–	–	0.12%	190
2024 Q4	$706K	Buy	20,703 +4,576	+28%	+$165K	0.1%	211
2024 Q3	$659K	Hold	16,127	–	–	0.1%	223
2024 Q2	$623K	Buy	16,127 +853	+6%	+$35.9K	0.1%	201
2024 Q1	$646K	Hold	15,274	–	–	0.09%	204
2023 Q4	$566K	Buy	+15,274	New	+$548K	0.1%	188

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

V-Square Quantitative Management's GSK Position: Q2 2026 in Review

V-Square Quantitative Management increased its GSK (GSK) stake by 75% in Q2 2026, buying an estimated $954K and bringing the position to 42,017 shares worth $2.2M. The position accounts for 0.21% of the portfolio, ranked #86.

V-Square Quantitative Management first reported a position in GSK in Q4 2023 and has held it in 11 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

V-Square Quantitative Management held 42,017 shares of GSK worth $2.2M as of Q2 2026.
V-Square Quantitative Management bought 18,030 GSK shares in Q2 2026, an estimated $954K.
GSK made up 0.21% of V-Square Quantitative Management's portfolio in Q2 2026, its #86 holding.
V-Square Quantitative Management first reported a position in GSK in Q4 2023 and has held it in 11 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.